Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 399.45 INR -1.38% Market Closed
Market Cap: 49.3B INR

Hikal Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikal Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Revenue
â‚ą18.2B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą312.3B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą269.8B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą516B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą113B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
â‚ą103.3B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Hikal Ltd
Glance View

Market Cap
49.3B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
356.36 INR
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Revenue?
Revenue
18.2B INR

Based on the financial report for Dec 31, 2024, Hikal Ltd's Revenue amounts to 18.2B INR.

What is Hikal Ltd's Revenue growth rate?
Revenue CAGR 5Y
3%

Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Hikal Ltd have been -3% over the past three years , 3% over the past five years .

Back to Top